MEDRAD STELLANT CT INJECTOR SYSTEM— 510(k) K023183

Substantially Equivalent

Medrad, Inc.

FDA 510(k) clearance K023183 for MEDRAD STELLANT CT INJECTOR SYSTEM, Substantially Equivalent on 2003-01-10. Applicant: Medrad, Inc.. Device class: 2.

Clearance details

Applicant
Medrad, Inc.
Product code
Code DXT
Device class
Class 2
Regulation
21 CFR 870.1650
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Special
Location
Indianola, PA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code DXT

view all

More clearances from Medrad, Inc.

view all

Adverse events under product code DXT

product code DXT
Death
39
Injury
242
Malfunction
463
Other
3
Total
747

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K023183

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K023183.

Data sourced from openFDA. This site is unofficial and independent of the FDA.